For research use only. Not for therapeutic Use.
ST-2001（Cat No.:I036674）is an investigational small molecule being studied for its potential therapeutic effects in cancer treatment. It is a selective inhibitor of the protein kinase CK2 (casein kinase 2), which plays a crucial role in regulating cell growth, survival, and DNA repair. CK2 is often dysregulated in various cancers, contributing to tumor progression and resistance to therapy. By inhibiting CK2, ST-2001 aims to suppress cancer cell proliferation and enhance the efficacy of other treatments. It is currently undergoing preclinical and early-stage clinical trials to assess its safety and therapeutic potential in oncology.
| Catalog Number | I036674 |
| Synonyms | ST-2001; ST2001; ST 2001; |
| Molecular Formula | C24H26N4O |
| Purity | 98% |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Reference | 1: Hagenow S, Affini A, Pioli EY, Hinz S, Zhao Y, Porras G, Namasivayam V, Müller CE, Lin JS, Bezard E, Stark H. Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease. J Med Chem. 2021 Jun 24;64(12):8246-8262. doi: 10.1021/acs.jmedchem.0c00914. Epub 2021 Jun 9. PMID: 34107215. |
